Drug recall
FLULAVAL QUADRIVALENT Carton NDC 19515-894-52 Syringe NDC 19515-894-41
FDA recall event 72602 · Class III · ID Biomedical Corp., a subsidary of GSK Biologicals
Key facts
| Event ID | 72602 |
|---|---|
| Recall numbers | B-0126-16 |
| Recalling firm | ID Biomedical Corp., a subsidary of GSK Biologicals |
| Product type | Biologics |
| Products | FLULAVAL QUADRIVALENT Carton NDC 19515-894-52 Syringe NDC 19515-894-41 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Certain lots of FLULAVAL QUADRIVALENT, with observed loss of potency below the minimum specification prior to product expiry, were distributed. |
| Initiation date | Apr 14, 2015 |
| Report date | Nov 25, 2015 |
| Termination date | Nov 18, 2015 |
| City | St. Foy |
| Country | Canada |
| FEI number | 3004835647 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: